Literature DB >> 8940202

Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1-dependent mechanism.

J E Gern1, B Joseph, D M Galagan, W R Borcherding, E C Dick.   

Abstract

To determine whether binding of human rhinovirus (HRV) to intracellular adhesion molecule-1 might disrupt airway immune processes, effects of a major HRV group, HRV-16, on T cell proliferation and cytotoxicity were defined. HRV (1-10 TCID50/cell) significantly inhibited T cell proliferation induced by antigen but not proliferation secondary to mitogens, interleukin-2, or an irradiated allogeneic T cell line. Noninfectious (UV-irradiated) HRV had similar effects. Inhibition of T cell proliferation was dependent on HRV binding to intercellular adhesion molecule-1 on monocytes, indicating that the virus interferes with lymphocyte activation indirectly through effects on antigen-presenting cells. In addition, HRV inhibited T cell cytotoxic responses but not NK cell activity. If these effects also occur in vivo, the resulting disturbance in local airway immunity could increase the chances of successful viral replication, and might also be a factor in the pathogenesis of secondary viral or bacterial respiratory tract infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940202     DOI: 10.1093/infdis/174.6.1143

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10.

Authors:  J Stöckl; H Vetr; O Majdic; G Zlabinger; E Kuechler; W Knapp
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Authors:  S B Deitz; D A Dodd; S Cooper; P Parham; K Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus.

Authors:  Nathan W Bartlett; Louise Slater; Nicholas Glanville; Jennifer J Haas; Gaetano Caramori; Paolo Casolari; Deborah L Clarke; Simon D Message; Julia Aniscenko; Tatiana Kebadze; Jie Zhu; Patrick Mallia; Joseph P Mizgerd; Maria Belvisi; Alberto Papi; Sergei V Kotenko; Sebastian L Johnston; Michael R Edwards
Journal:  EMBO Mol Med       Date:  2012-11-14       Impact factor: 12.137

Review 4.  Rhinoviruses in the pathogenesis of asthma.

Authors:  Nikolaos G Papadopoulos; Stelios Psarras
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

Review 5.  Rhinoviruses, allergic inflammation, and asthma.

Authors:  Monica L Gavala; Paul J Bertics; James E Gern
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 6.  Rhinovirus infections: induction and modulation of airways inflammation in asthma.

Authors:  K Grünberg; P J Sterk
Journal:  Clin Exp Allergy       Date:  1999-06       Impact factor: 5.018

7.  Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia.

Authors:  Michael G Ison; Frederick G Hayden; Laurent Kaiser; Lawrence Corey; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2003-04-21       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.